Advertisement
U.S. markets closed

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.9945+0.0045 (+0.45%)
At close: 04:00PM EST
0.9700 -0.02 (-2.46%)
After hours: 07:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.9900
Open0.9824
Bid0.9709 x 400
Ask1.0200 x 100
Day's Range0.9602 - 1.0200
52 Week Range0.7040 - 11.4100
Volume552,840
Avg. Volume965,731
Market Cap45.35M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-1.8400
Earnings DateNov 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.33
  • GlobeNewswire

    Verrica Announces Pricing of $42.0 Million Public Offering

    WEST CHESTER, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of an underwritten public offering of 44,964,045 shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 2,235,955 shares of its common stock, and in either case, acco

  • GlobeNewswire

    Verrica Announces Proposed Public Offering

    WEST CHESTER, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and in either case, accompanying warrants to purchase shares of its common stock, in an underwritten public offering.